Literature DB >> 2033698

Electromagnetic extracorporeal shock wave lithotripsy in children.

H Vandeursen1, P Devos, L Baert.   

Abstract

Extracorporeal shock wave lithotripsy (ESWL) was performed for the treatment of urinary tract calculi in 28 children. All treatments were done with the standard Siemens Lithostar device in situ: no special adaptations for adequate positioning of children are required to target the stone precisely. A total of 42 calculi in 30 renal units was treated, requiring 50 ESWL sessions. The mean energy used was 16.4 kv. and the number of shock waves averaged 3,188. Mean fluoroscopy time per session was 1.5 minutes. In 26 of 50 sessions (52%) general anesthesia was needed for the child to remain perfectly still. A complete stone-free rate was achieved in 38 of 42 calculi (90.5%): after 1 session in 30 (71.4%), after 2 sessions in 6 (13.7%) and after 3 sessions in 2 (4.8%). Five staghorn calculi were treated with ESWL monotherapy. A complete stone-free result was obtained after 3 treatments in 2 patients, while 2 had residual fragments in the lower pole (5 mm. after 6 sessions and 11 months of followup in 1, and 7 mm. after 3 sessions and 3 months of followup in 1). A cystine staghorn stone necessitated open nephrolithotomy after 3 sessions without any fragmentation. One impacted sacroiliac ureteral stone required endoscopic laser lithotripsy. Except for these 2 failures no adjuvant procedures were needed. There were no intraoperative or postoperative complications and minor skin bruising at the coupling site after 3 treatments did not require any therapy. We conclude that electromagnetic ESWL with the standard Lithostar unit is a safe and effective method to treat calculi throughout the urinary tract in children.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2033698     DOI: 10.1016/s0022-5347(17)38583-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

Review 1.  Treatment update on pediatric urolithiasis.

Authors:  T Esen; A Krautschick; P Alken
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

2.  Efficacy of extracorporeal shock wave lithotripsy for ureteric stones in children.

Authors:  Ahmet Yaser Muslumanoglu; Ahmet Hamdi Tefekli; Fatih Altunrende; Mert Ali Karadag; Murat Baykal; Muzaffer Akcay
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

3.  Extracorporeal shock wave lithotripsy in the management of pediatric urolithiasis.

Authors:  A Slavkovic; M Radovanovic; M Vlajkovic; D Novakovic; N Djordjevic; V Stefanovic
Journal:  Urol Res       Date:  2006-07-26

4.  Extracorporeal shockwave lithotripsy under sedoanalgesia for treatment of kidney stones in infants: a single-center experience with 102 cases.

Authors:  Senol Adanur; Tevfik Ziypak; Ali Haydar Yılmaz; Huseyin Kocakgol; Mehmet Aksoy; Turgut Yapanoglu; Ozkan Polat; Yılmaz Aksoy
Journal:  Int Urol Nephrol       Date:  2014-07-31       Impact factor: 2.370

5.  Shock wave lithotripsy is effective and safe for distal ureteral calculi in children.

Authors:  Isa Ozbey; Yilmaz Aksoy; Tevfik Ziypak; Turgut Yapanoglu; Ozkan Polat; Mehmet Aksoy
Journal:  Urol Res       Date:  2007-08-01

6.  Efficacy of extracorporeal shock wave lithotripsy for ureteral stones in children.

Authors:  Jianlin Lu; Xizhao Sun; Lei He; Ying Wang
Journal:  Pediatr Surg Int       Date:  2009-10-09       Impact factor: 1.827

7.  Epidemiology of paediatric renal stone disease in the UK.

Authors:  R J M Coward; C J Peters; P G Duffy; D Corry; M J Kellett; S Choong; W G van't Hoff
Journal:  Arch Dis Child       Date:  2003-11       Impact factor: 3.791

8.  Treatment of Kidney Stones Using Extracorporeal Shock Wave Lithotripsy (ESWL) and Double-J Stent in Infants.

Authors:  Mehdi Younesi Rostami; Mehrdad Taghipour-Gorgikolai; Rayka Sharifian
Journal:  Adv Urol       Date:  2012-04-09

9.  Efficacy of extracorporeal shock wave lithotripsy in pediatric and adolescent urolithiasis.

Authors:  Joon Yeop Jee; Soo Dong Kim; Won Yeol Cho
Journal:  Korean J Urol       Date:  2013-12-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.